Breaking News Headlines Today

News from Pharmaphorum

See all of Pharmaphorum news coverage in one place. Discover how Pharmaphorum’s media bias informs their coverage and compare with thousands of other news outlets.

We’ve aggregated 423 of Pharmaphorum’s headlines and news stories over the past 3 months.

The Ground News media bias check for Pharmaphorum is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

If you want to know if Pharmaphorum is credible or reliable, look no further. We rank Pharmaphorum as High factuality. Find out more about our methodology here.

Information about Pharmaphorum

Where is Pharmaphorum located?Pharmaphorum's Website

Media Bias Ratings

Average Bias Rating:

Center

byAd Fontes Media

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Hengrui Pharma’s Potential Rival to El Lilly’s Zepbound Leads to 18% Weight Loss in Key Study

100% Center coverage: 6 sources

The Phase 3 results in China are encouraging for Kailera Therapeutics, which holds rights to the molecule in the rest of the world. The startup is preparing a global clinical development program for this drug, a once-weekly injectable GLP-1 and GIP receptor agonist.See the Story

Takeda Stock Rises After Positive Phase 3 Results for Narcolepsy Drug

60% Center coverage: 5 sources

Takeda will move quickly ahead with regulatory filings for oveporexton as a treatment for narcolepsy after a pair of phase 3 wins.Wall Street See the Story

Finerenone Gets Expanded FDA Approval in Heart Failure

100% Center coverage: 4 sources

(MedPage Today) -- The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced. The nonsteroidal mineralocorticoid receptor antagonist (MRA) is the first of its class to win approval for treating...United States · United States See the Story

The Inaugural Market Access for CNS Therapeutics Summit Has Arrived!

100% Center coverage: 1 sources

The Inaugural Market Access for CNS Therapeutics Summit Has Arrived! Sara.Scarpinati Tue, 15/07/2025 - 08:26 Bookmark this Read Article

New Cystic Fibrosis Triple From Vertex Backed for NHS Use

100% Center coverage: 1 sources

Vertex has won NICE's backing for a new cystic fibrosis therapy, Alyftrek, that could be an option for 89% of NHS patients with the genetic disorder.NHS · England See the Story

What to do when your grant application fails

100% Center coverage: 1 sources

All hope should not be lost and an unsuccessful application doesn’t always mark the end of the road. Businesses can gain valuable insights and learnings from the process, helping them refine their approach and strengthen future applications.Read Article

Post-hype, pre-value: The real AI-pharma shift starts now

100% Center coverage: 1 sources

The first era of AI in pharma was built on potential. This next era will be built on proof, reinforcing even greater potential.Artificial Intelligence Read Article

UK project addresses capacity issue in CGT manufacturing

100% Center coverage: 1 sources

A UK consortium has been set up to tackle a major issue in the development of cell and gene therapies (CGT) – a lack of manufacturing capacity.See the Story

LEO Bulks up with Deal for Boehringer Skin Drug

100% Center coverage: 1 sources

LEO Pharma has licensed a medicine for a rare form of psoriasis from Boehringer Ingelheim, plugging a gap in its near-term product portfolio.Pharma See the Story

News from Pharmaphorum

News from Pharmaphorum

Information about Pharmaphorum

Media Bias Ratings

Factuality

Ownership

Top Pharmaphorum News

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

UK Biobank Completes World's Largest 100,000-Volunteer Whole-Body Imaging Study

Hengrui Pharma’s Potential Rival to El Lilly’s Zepbound Leads to 18% Weight Loss in Key Study

Takeda Stock Rises After Positive Phase 3 Results for Narcolepsy Drug

Finerenone Gets Expanded FDA Approval in Heart Failure

The Inaugural Market Access for CNS Therapeutics Summit Has Arrived!

New Cystic Fibrosis Triple From Vertex Backed for NHS Use

What to do when your grant application fails

Post-hype, pre-value: The real AI-pharma shift starts now

UK project addresses capacity issue in CGT manufacturing

LEO Bulks up with Deal for Boehringer Skin Drug

Similar News Topics

Topics Most Covered by Pharmaphorum

Sources Covering Similar Topics

Breaking News Topics Related to Pharmaphorum